Heron Therapeutics Ownership | Who Owns Heron Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Heron Therapeutics Ownership Summary


Heron Therapeutics is owned by 85.72% institutional investors, 0.72% insiders, and 13.56% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 17.67% of HRTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.09% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHeron Therapeutics85.72%0.72%13.56%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp26.71M17.67%$93.50M
Vanguard group8.62M5.70%$30.16M
Blackrock8.33M5.51%$29.14M
Adage capital partners gp7.60M5.03%$26.60M
Velan capital investment management lp6.99M4.62%$24.45M
Franklin resources6.33M4.18%$22.15M
State street5.28M3.49%$18.48M
Tejara capital4.19M2.77%$14.66M
Palisade capital management, lp4.05M2.68%$14.17M
D. e. shaw3.86M2.56%$13.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp6.99M14.01%$24.45M
Tejara capital4.19M5.33%$14.66M
Jw asset management2.29M3.31%$8.02M
Richmond brothers356.56K2.47%$1.25M
Rubric capital management lp26.71M2.45%$93.50M
Orchard capital management2.24M2.37%$7.85M
Congress park capital1.58M2.22%$5.52M
Cm management300.00K0.96%$1.05M
Monaco asset management sam1.51M0.84%$5.30M
Tang capital management1.85M0.66%$6.47M

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp7.60M0.05%4.69M
State street5.28M0.00%2.84M
Marshall wace, llp1.76M0.01%1.27M
D. e. shaw3.86M0.01%1.17M
Blackrock8.33M0.00%1.04M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---6.51M
Millennium management1.43M0.00%-1.73M
Clearline capital lp1.50M0.14%-1.28M
Essex investment management---695.99K
Renaissance1.99M0.01%-412.69K

New Positions

HolderShares% AssetsChangeValue
State of wisconsin investment board143.00K0.00%143.00K$500.51K
Corebridge financial63.16K0.00%63.16K$221.06K
Mirae asset global etfs61.76K0.00%61.76K$215.29K
Group one trading54.25K0.00%54.25K$189.88K
Synovus financial31.85K0.00%31.85K$111.47K

Sold Out

HolderChange
Toronto dominion bank-9.00
Lindbrook capital-16.00
Gps wealth strategies group-72.00
Financial gravity asset management-75.00
Rothschild investment-85.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202419417.58%129,609,4628.61%851.36%11359.15%39-17.02%
Mar 31, 20241655.77%119,336,2116.43%791.33%71-4.05%4727.03%
Dec 31, 202315611.43%112,127,927-4.94%770.80%7442.31%37-5.13%
Sep 30, 2023140-6.04%117,952,08919.93%981.45%52-14.75%39-15.22%
Jun 30, 2023149-8.02%98,354,908-8.65%821.01%61-46-13.21%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.68M3.09%-
iShares Russell 2000 ETF3.04M2.00%-6.83K
Biotech Growth Ord2.58M1.70%2.58M
Palisade Small Cap Core Equity2.47M1.63%-98.19K
Vanguard Institutional Extnd Mkt Idx Tr2.38M1.57%40.27K
Orchard US Small Cap Value USD Instl 12.02M1.33%-
Orchard Small Cap Value ESG2.02M1.33%1.99M
Franklin US Small Cap Growth Equity1.80M1.19%-
Fidelity Small Cap Index1.20M0.79%-26.07K
iShares Russell 2000 Value ETF1.00M0.66%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 17, 2023Forbes William P EVP, Chief Development OfficerBuy$27.25K
Nov 16, 2023Forbes William P EVP, Chief Development OfficerBuy$46.99K
Nov 16, 2023Collard Craig A Chief Executive OfficerBuy$137.97K
Nov 16, 2023Duarte Ira EVP, Chief Financial OfficerBuy$75.60K
Jul 21, 2023Morgan Adam-Buy$3.41M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q44-

HRTX Ownership FAQ


Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 85.72%, followed by 0.72% insiders and 13.56% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 45.43%, which Heron Therapeutics exceeds.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (26.71M shares, 17.67%), Vanguard group (8.62M shares, 5.70%), and Blackrock (8.33M shares, 5.51%). Together, they hold 28.87% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 14.01% of its assets in 6.99M Heron Therapeutics shares, valued at 24.45M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Heron Therapeutics shares, with 3.09% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools